Search results for "Rectal Cancer"

showing 10 items of 978 documents

The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer.

2007

An efficient cytolytic T cell function is essential for immune mediated rejection of colorectal cancer. However, the molecular mechanisms driving T cell mediated cancer rejection are still poorly understood. Here, we assessed the relevance of the T-box transcription factor eomesodermin in colorectal cancer. METHODS/ RESULTS: By analysing tissue probes from 88 different colorectal tumours, a significant (p0.02) inverse correlation between eomesodermin expression in colorectal cancers and the presence of lymph node metastases could be shown, whereas no such correlation was noted for the master transcription factor of regulatory T cells, FoxP3 and CD8 alpha expression. To evaluate whether this…

MaleT cellEomesoderminEnzyme-Linked Immunosorbent AssayCD8-Positive T-LymphocytesTransforming Growth Factor betamedicineCytotoxic T cellHumansTranscription factorColorectal Cancerbiologybusiness.industryReverse Transcriptase Polymerase Chain ReactionGastroenterologyCancerT lymphocytemedicine.diseasemedicine.anatomical_structurePerforinLymphatic MetastasisImmunologybiology.proteinFemaleInterleukin-4businessColorectal NeoplasmsT-Box Domain ProteinsCD8Gut
researchProduct

Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy

2016

AIM To study the tolerance and the efficiency of FOLFIRINOX in elderly patients diagnosed with colorectal or pancreatic cancer. METHODS This retrospective study included elderly patients aged over 70 years of age treated at Georges-Francois Leclerc Center by FOLFIRINOX for histological proved colorectal or pancreatic cancer between January 2009 and January 2015. Chemotheapy regimen consisted of oxaliplatin (85 mg/m(2) in over 120 min) followed by leucovorin (400 mg/m(2) in over 120 min), with the addition, after 30 min of irinotecan (180 mg/m(2) in over 90 min) then 5 fluorouracil (5FU) (400 mg/m(2) administred intravenous bolus), followed by 5FU (2400 mg/m2 intraveinous infusion over 46 h)…

MaleTime FactorsOrganoplatinum CompoundsColorectal cancerFOLFIRINOXLeucovorinPooled AnalysisInternational-SocietyKaplan-Meier EstimateOlder PatientsGastroenterology0302 clinical medicineRisk FactorsAntineoplastic Combined Chemotherapy Protocols030212 general & internal medicineAged 80 and overAge FactorsGastroenterologyCommon Terminology Criteria for Adverse EventsGeneral Medicine3. Good healthOxaliplatinTreatment Outcome030220 oncology & carcinogenesisDisease ProgressionFolfirinoxFemale[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyFluorouracilFranceFolfirinox RegimenColorectal Neoplasmsmedicine.drugmedicine.medical_specialtyOxaliplatin FolfirinoxIrinotecanDisease-Free SurvivalDrug Administration Schedule03 medical and health sciencesPancreatic CancerRetrospective StudyInternal medicinePancreatic cancermedicineHumansChemotherapyGeriatric AssessmentAgedRetrospective StudiesColorectal CancerChi-Square DistributionPerformance statusbusiness.industry[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyElderly Patientsmedicine.diseasePhase-Ii Trial1st-Line TreatmentSurgeryPancreatic NeoplasmsIrinotecanRegimenMultivariate AnalysisCamptothecinOpen-LabelFeasibility TreatmentTomography X-Ray Computedbusiness
researchProduct

Elevated AA/EPA Ratio Represents an Inflammatory Biomarker in Tumor Tissue of Metastatic Colorectal Cancer Patients

2019

Chronic inflammation increases the risk of developing certain types of cancer, such as colorectal cancer (CRC). The oxidative metabolism of polyunsaturated fatty acids (PUFAs) has a strong effect on colonic tumorigenesis and the levels of arachidonic acid (AA) and eicosapentaenoic acid (EPA) can contribute to the development of an inflammatory microenvironment. Aim of this study was to evaluate the possible differences in the AA/EPA ratio tissue levels between CRC patients with and without synchronous metastases. Moreover, the expression of the most important inflammatory enzymes and mediators, linked with the AA/EPA ratio, have been also assessed. Sixty-eight patients with CRC were enrolle…

Maleeicosapentaenoic acidColorectal cancermedicine.disease_causeMetastasislcsh:ChemistryReceptor Cannabinoid CB2chemistry.chemical_compoundMedicineArachidonate 15-LipoxygenaseNeoplasm Metastasislcsh:QH301-705.5Spectroscopychemistry.chemical_classificationGeneral MedicineEicosapentaenoic acidComputer Science ApplicationsGene Expression Regulation NeoplasticArachidonic acidArachidonic acidFemalelipids (amino acids peptides and proteins)medicine.symptomColorectal NeoplasmsPolyunsaturated fatty acidInflammationcolorectal cancerCatalysisArticleInorganic ChemistryBiomarkers TumorHumansmetastasisRNA MessengerPhysical and Theoretical ChemistryMolecular BiologyAgedInflammationbusiness.industryOrganic Chemistryinflammatory biomarkerCancermedicine.diseasePPAR gammalcsh:Biology (General)lcsh:QD1-999chemistryCancer researchbusinessCarcinogenesisInternational Journal of Molecular Sciences
researchProduct

Socio-demographic, health-related, and individual correlates of diagnostic self-testing by lay people: Results from a representative survey in Germany

2017

Introduction A broad range of self-tests (testing for e.g. HIV, cancer, hepatitis B/C) have become available and can be conducted by lay consumers without the help of a health professional. The aims of this study were to (a) investigate the prevalence of self-testing, (b) identify the most frequently used self-tests, and (c) explore the associations between socio-demographic, health-related and individual factors with self-testing. Methods A face-to-face plus paper-pencil cross-sectional survey was conducted. The sample consisted of 2.527 respondents who were representative of the German population in terms of the age, sex, and residence. Basic descriptive statistics and univariate logistic…

Malelcsh:MedicinePathology and Laboratory MedicineLogistic regressionGeographical locationsEndocrinology0302 clinical medicineSurveys and QuestionnairesGermanyDiagnosisMedicine and Health Sciences030212 general & internal medicineComputer Networkslcsh:ScienceFatigueMultidisciplinary030503 health policy & servicesAttendanceEuropeLaypersonOncologyFemaleAnatomy0305 other medical sciencePsychologyResearch ArticleAdultComputer and Information SciencesEndocrine Disorders03 medical and health sciencesSigns and SymptomsDiagnostic MedicineMental Health and PsychiatryCancer Detection and DiagnosisDiabetes MellitusHumansEuropean UnionDemographyColorectal CancerInternetDescriptive statisticslcsh:RUnivariateCancers and NeoplasmsBiology and Life SciencesLife satisfactionKidneysRenal SystemSelf CareSocial ClassMetabolic Disorderslcsh:QResidencePeople and placesRural areaDemographyPLOS ONE
researchProduct

Epidemiology and prognosis of synchronous colorectal cancers

2008

Abstract Background The aim of this population-based study was to report on the incidence, treatment and prognosis of synchronous colorectal carcinomas. Methods Data were obtained from the population-based cancer registry of Burgundy. Results Between 1976 and 2004, 15 562 colorectal cancers were diagnosed. Some 3·8 per cent of patients had synchronous colorectal cancers. The risk of having synchronous cancers was higher in men (odds ratio (OR) 1·41 (95 per cent confidence interval (c.i.) 1·19 to 1·68)), when associated adenomas were present (OR 2·02 (95 per cent c.i. 1·69 to 2·41)), when there were adenomatous remnants on pathological examination (OR 2·10 (95 per cent c.i. 1·73 to 2·55)) an…

Malemedicine.medical_specialtyAdenomaColorectal cancerPopulationGastroenterologyNeoplasms Multiple PrimaryRisk FactorsInternal medicinemedicineHumanseducationAgedRetrospective Studieseducation.field_of_studyRelative survivalbusiness.industryIncidenceIncidence (epidemiology)CancerOdds ratioMiddle AgedPrognosismedicine.diseaseSurgeryCancer registryFemaleSurgeryFranceColorectal NeoplasmsbusinessBritish Journal of Surgery
researchProduct

Unexplained neoplastic anastomotic recurrence after right hemicolectomy: a case report

2020

Abstract Background Anastomotic recurrences of the colon are postulated to arise due to inadequate margins, tumor implantation by exfoliated cells, altered biological properties of bowel anastomosis, and missed synchronous lesions. In this paper, a case of unexpected early local recurrence after surgery for colon cancer is presented. Case presentation A 68-year-old Caucasian man underwent right hemicolectomy for invasive G2 adenocarcinoma. Two months later, endoscopy revealed a wide and well-functioning anastomosis with a hyperemic, hard, and thickened mucosal area of about 2 cm in diameter. Biopsies showed the presence of an adenocarcinoma with the same grading of the previous lesion. Ten …

Malemedicine.medical_specialtyColectomiesAnastomotic recurrenceColorectal cancerColon carcinomalcsh:MedicineAnastomosis03 medical and health sciences0302 clinical medicineCase reportmedicineAdjuvant therapyHumansGrading (tumors)ColectomyAgedmedicine.diagnostic_testbusiness.industryAnastomosis Surgicallcsh:RTransverse colonRight hemicolectomyGeneral Medicinemedicine.diseaseEndoscopySurgery030220 oncology & carcinogenesisColonic NeoplasmsAdenocarcinoma030211 gastroenterology & hepatologyNeoplasm Recurrence Localbusiness
researchProduct

Predictors of complications and mortality following left colectomy with primary stapled anastomosis for cancer: results of a multicentric study with …

2018

Aim Reports detailing the morbidity-mortality after left colectomy are sparse and do not allow definitive conclusions to be drawn. We aimed to identify risk factors for anastomotic leakage, perioperative mortality and complications following left colectomy for colonic malignancies. Method We undertook a STROBE-compliant analysis of left colectomies included in a national prospective online database. Forty-two variables were analysed as potential independent risk factors for anastomotic leakage, postoperative morbidity and mortality. Variables were selected using the 'least absolute shrinkage and selection operator' (LASSO) method. Results We analysed 1111 patients. Eight per cent of patient…

Malemedicine.medical_specialtyColectomiesDatabases FactualColorectal cancerColonanastomotic leak030230 surgeryLower risk03 medical and health sciencesLiver disease0302 clinical medicineRisk FactorsSurgical StaplingmedicineHumansstapled anastomosipostoperative complicationProspective Studiesleft colectomyColectomyAgedbusiness.industryAnastomosis SurgicalGastroenterologyPostoperative complicationPerioperativeMiddle Agedmedicine.diseaseSurgeryColon cancerParenteral nutritionTreatment Outcome030220 oncology & carcinogenesisColonic NeoplasmsFemalebusinessComplication
researchProduct

Total mesorectal excision with intraoperative assessment of internal anal sphincter innervation provides new insights into neurogenic incontinence

2012

Background: The aim of this prospective study was to assess internal anal sphincter (IAS) innervation in patients undergoing total mesorectal excision (TME) by intraoperative neuromonitoring (IONM). Study Design: Fourteen patients underwent TME. IONM was carried out through pelvic splanchnic nerve stimulation under continuous electromyography of the IAS. Anorectal function was assessed with the digital rectal examination scoring system and a standardized questionnaire. Results: Nine of 11 patients who underwent low anterior resection had positive IONM results, with stimulation-induced increased IAS electromyographic amplitudes (median 0.23 V (interquartile range [IQR] 0.05, 0.56) vs median …

Malemedicine.medical_specialtyColorectal cancerAnal CanalElectromyographyAutonomic Nervous SystemInternal anal sphincterInterquartile rangeMonitoring IntraoperativeSurveys and QuestionnairesHumansMedicineFecal incontinenceProspective StudiesProspective cohort studyAgedAged 80 and overmedicine.diagnostic_testElectromyographyRectal Neoplasmsbusiness.industryRectumRectal examinationMiddle Agedmedicine.diseaseTotal mesorectal excisionSurgeryTreatment OutcomeFeasibility StudiesFemaleSurgerymedicine.symptombusinessFecal Incontinence
researchProduct

Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study

2000

BACKGROUND—Marked differences in population based survival across Europe were found for colorectal cancers diagnosed in 1985-1989.
AIMS—To understand the reasons for these differences in survival in a new analysis of colorectal cancers diagnosed between 1988 and 1991.
SUBJECTS—A total of 2720 patients with adenocarcinoma of the large bowel from 11 European cancer registries (CRs).
METHODS—We obtained information on stage at diagnosis, diagnostic determinants, and surgical treatment (not routinely collected by CRs) and analysed the data in relation to three year observed survival, calculating relative risks (RRs) of death and adjusting for age, sex, site, stage, and determinants of stage.
RE…

Malemedicine.medical_specialtyColorectal cancerColorectal cancer; Europe; Population based cancer registries; Stage at diagnosis; Surgery; Survival;-AdenocarcinomaArticleInternal medicinemedicineCarcinomaHumansRegistriesStage (cooking)Sex DistributionLetters to the EditorSurvival rateNeoplasm Stagingbusiness.industryGastroenterologyCancermedicine.diseaseConfidence intervalSurgeryEuropeSurvival RateRelative riskAdenocarcinomaFemalebusinessColorectal Neoplasms
researchProduct

Relationship of curative surgery on natural killer cell activity in colorectal cancer.

1996

Aim of this study has been to evaluate natural killer (NK) activity in patients with colorectal tumors before and after curative surgery.Forty colorectal cancer patients without distant metastases were stratified according to American Joint Committee on Cancer/International Union Against Cancer staging system into three categories: Stage I (n = 12), Stage II (n = 15), and Stage III (n = 13). All of them underwent curative resection, and there were no major postoperative complications. Venous blood samples were obtained preoperatively, at surgical wound closure, and on the 1st, 7th, and 21st postoperative days. Mononuclear cells were isolated over Ficoll-Hypaque (Lymphoprep, Nycomed Pharma A…

Malemedicine.medical_specialtyColorectal cancerGastroenterologyNatural killer cellSurgical oncologyInternal medicineCarcinomaMedicineHumansPostoperative PeriodStage (cooking)Cancer stagingAgedNeoplasm Stagingbusiness.industryGastroenterologyCancerGeneral MedicineMiddle Agedmedicine.diseaseCytotoxicity Tests ImmunologicColorectal surgerySurgeryKiller Cells Naturalmedicine.anatomical_structureCase-Control StudiesFemalebusinessColorectal NeoplasmsDiseases of the colon and rectum
researchProduct